Blocknomi
TLDR Shares of AlzeCure Pharma skyrocketed more than 301% following news of a licensing partnership with Eli Lilly for Alzheimer’s candidate Alzstatin ACD680 Total transaction value may surpass $1 billion,…
Related articles
-
SpaceX targets record $75 billion IPO as bitcoin treasury and liquidity risks draw focus
CoinDesk Published 03.06.2026 22:31
-
Bloom Energy (BE) Stock Drops 6% as Major Data Center Deal Hits the Brakes
Blocknomi Published 10.06.2026 18:13
-
Elizabeth Warren Calls on SEC to Halt SpaceX’s $2 Trillion IPO Ahead of June 12 Launch
Blocknomi Published 10.06.2026 16:43
-
Will Strategy's Peers Dump Bitcoin Now? Not so Fast, Analysts Say
Decrypt Published 02.06.2026 16:31
-
Guild Wars 3 Domain Rumors: Why Web3 MMOs Need AAA-Level Community Signals
Crypto Daily Published 11.06.2026 12:31
-
Arthur Hayes dumps HYPE, NEAR as he warns of AI IPO wave
Cointelegraph Published 04.06.2026 13:04
-
HYPE Leads the Relief Bounce: Is Hyperliquid Recovering From Unlock Pressure or Just Beta?
Crypto Daily Published 12.06.2026 12:51
-
World Cup Betting With USDT: Wallet Setup, Live Markets, and Early Cash Out
Crypto Daily Published 08.06.2026 15:16